Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OST Développement is a specialized medical device company focused on the design and manufacturing of orthopedic implants for the extremities, with a primary emphasis on foot and ankle surgery. Founded in 2004 and based in Gerzat, France, the company provides a comprehensive portfolio of surgical solutions, including compression screws, plating systems, and staples for indications such as hallux valgus and fracture fixation. OST Développement is known for its "Osteo Surface Technology" and high-precision manufacturing capabilities that ensure optimal biocompatibility and mechanical performance. The company was acquired by Novastep and subsequently became part of Enovis (formerly Colfax) following its acquisition of Novastep in 2023. It continues to serve as a critical R&D and production site for advanced podiatric surgical technologies within the global Enovis organization. The company's products are distributed globally and are recognized for their clinical efficacy in complex reconstructive surgeries of the lower limb.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on O.S.T. Développement.